Compound E, chemically designated as 209986-17-4 (CAS), represents a significant exploration within the field of Alzheimer's disease research. This γ-secretase blocking agent was initially developed as a potential https://harmonyojxd313358.mpeblog.com/73264781/γ-secretase-suppressor-compound-e-209986-17-4